VERADERMICS Stock Price, News & Analysis
Why is MANE Stock Up Today?
Company Description
VERADERMICS (NYSE: MANE) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $2.1B, ranking #2,157 among all listed U.S. companies by market cap.
MANE stock has gained 70.0% over the past year. Shares last traded at $64.19.
On a trailing twelve-month basis, VERADERMICS reported net income of -$70.0M and diluted earnings per share of $-111.91.
This page provides a comprehensive overview of MANE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
VERADERMICS (MANE) stock last traded at $64.19. Over the past 12 months, the stock has gained 70.0%. At a market capitalization of $2.1B, MANE is classified as a mid-cap stock with approximately 37.3M shares outstanding.
Latest News
VERADERMICS has 7 recent news articles, with the latest published 4 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, IPO, clinical trial, offering. View all MANE news →
SEC Filings
VERADERMICS has filed 5 recent SEC filings, including 1 Form 10-K, 1 Form 8-K, 1 Form 4/A, 1 Form SCHEDULE 13D. The most recent filing was submitted on March 30, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MANE SEC filings →
Insider Radar
Insider buying activity at VERADERMICS over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
operating income reached -$72.3M, and net income was -$70.0M. Diluted earnings per share stood at $-111.91. The company generated -$71.6M in operating cash flow. With a current ratio of 16.66, the balance sheet reflects a strong liquidity position.
Upcoming Events
Phase 3 '304' topline data
Study 304 topline readout
VERADERMICS has 2 upcoming scheduled events. The next event, "Phase 3 '304' topline data", is scheduled for July 1, 2026 (in 89 days). Investors can track these dates to stay informed about potential catalysts that may affect the MANE stock price.
Short Interest History
Short interest in VERADERMICS (MANE) currently stands at 1.4 million shares, up 10.2% from the previous reporting period, representing 4.1% of the float. Over the past 12 months, short interest has increased by 35.1%. This relatively low short interest suggests limited bearish sentiment. The 5.4 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for VERADERMICS (MANE) currently stands at 5.4 days, up 213.5% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 213.5% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.7 to 5.4 days.
MANE Company Profile & Sector Positioning
VERADERMICS (MANE) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NYSE.